Ian KingMadison Muller / bloomberg - Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.
Back to Top / Monday, January 12, 2026, 4:21 pm / permalink 17797 / 6 stories in 7 wks
Anthropic expands healthcare services with new AI chatbot capabilities amid competitive pressure / 7 wks
Barcelona’s Biorce Secures Series A Funding for AI Clinical Trials Expansion / 4 wks
Nvidia CEO dismisses ‘doomer’ AI narratives amid growing industry optimism / 7 wks
Nvidia launches Rubin CPX GPU for long-context AI tasks / 5 months
Nvidia unveils Blackwell GPUs and agentic AI models at SIGGRAPH 2025 / 6 months
German Recare Successfully Secures €37M Funding Round to Accelerate AI-Driven Hospital Solutions / 5 wks
Outpost Bio lands $3.5M to turn the microbiome into predictive AI infrastructure / 4 days
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.